# Mature B-Cell Lymphoma And Leukemia Study III

> **NCT01046825** · PHASE2,PHASE3 · ACTIVE_NOT_RECRUITING · sponsor: **St. Jude Children's Research Hospital** · enrollment: 128 (actual)

## Conditions studied

- Mature B-Cell Lymphoma

## Interventions

- **DRUG:** COPAD
- **DRUG:** COP, COPD M3, CYM
- **DRUG:** COP, COPADM8, CYVE

## Key facts

- **NCT ID:** NCT01046825
- **Lead sponsor:** St. Jude Children's Research Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2010-09-09
- **Primary completion:** 2023-08-31
- **Final completion:** 2027-08
- **Target enrollment:** 128 (ACTUAL)
- **Last updated:** 2025-12-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01046825

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01046825, "Mature B-Cell Lymphoma And Leukemia Study III". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT01046825. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*